Professor Vince Emery

i-sense, the EPSRC IRC in Early Warning Systems for infectious Diseases

Protecting patients and populations from the threat of infectious diseases

Globally, infectious diseases such as influenza, MRSA and HIV rank  among the gravest threats to human health, alongside global warming and terrorism. 

i-sense is a five-year, £11m EPSRC-funded interdisciplinary programme, launched in October 2013. It aims to engineer a new generation of early-warning sensing systems to identify disease outbreaks much earlier than before, using self-reported symptoms on the web and mobile phone-connected diagnostic tests.

Read more

Contact Me

E-mail:
Phone: 01483 68 9119

Find me on campus
Room: 14 SE 03

Publications

Highlights

  • Marashi SM, Raeiszadeh M, Enright V, Tahami F, Workman S, Chee R, Webster AD, Milne RS, Emery VC. (2012) 'Influence of cytomegalovirus infection on immune cell phenotypes in patients with common variable immunodeficiency.'. J Allergy Clin Immunol, United States: 129 (5), pp. 1349-1356.e3.
  • Marashi SM, Raeiszadeh M, Workman S, Rahbar A, Soderberg-Naucler C, Klenerman P, Chee R, Webster AD, Milne RS, Emery VC. (2011) 'Inflammation in common variable immunodeficiency is associated with a distinct CD8(+) response to cytomegalovirus.'. J Allergy Clin Immunol, United States: 127 (6), pp. 1385-93.e4.
  • Griffiths PD, Stanton A, McCarrell E, Smith C, Osman M, Harber M, Davenport A, Jones G, Wheeler DC, O'Beirne J, Thorburn D, Patch D, Atkinson CE, Pichon S, Sweny P, Lanzman M, Woodford E, Rothwell E, Old N, Kinyanjui R, Haque T, Atabani S, Luck S, Prideaux S, Milne RS, Emery VC, Burroughs AK. (2011) 'Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial.'. Lancet, England: 377 (9773), pp. 1256-1263.
  • Shannon-Lowe CD, Emery VC. (2010) 'The effects of maribavir on the autophosphorylation of ganciclovir resistant mutants of the cytomegalovirus UL97 protein.'. Herpesviridae, England: 1 (1)
  • Nebbia G, Mattes FM, Smith C, Hainsworth E, Kopycinski J, Burroughs A, Griffiths PD, Klenerman P, Emery VC. (2008) 'Polyfunctional cytomegalovirus-specific CD4+ and pp65 CD8+ T cells protect against high-level replication after liver transplantation.'. Am J Transplant, Denmark: 8 (12), pp. 2590-2599.
  • Mattes FM, Vargas A, Kopycinski J, Hainsworth EG, Sweny P, Nebbia G, Bazeos A, Lowdell M, Klenerman P, Phillips RE, Griffiths PD, Emery VC. (2008) 'Functional impairment of cytomegalovirus specific CD8 T cells predicts high-level replication after renal transplantation.'. Am J Transplant, Denmark: 8 (5), pp. 990-999.
  • Mattes FM, Hainsworth EG, Hassan-Walker AF, Burroughs AK, Sweny P, Griffiths PD, Emery VC. (2005) 'Kinetics of cytomegalovirus load decrease in solid-organ transplant recipients after preemptive therapy with valganciclovir.'. J Infect Dis, United States: 191 (1), pp. 89-92.
  • Deayton JR, Prof Sabin CA, Johnson MA, Emery VC, Wilson P, Griffiths PD. (2004) 'Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy.'. Lancet, England: 363 (9427), pp. 2116-2121.
  • Aubert G, Hassan-Walker AF, Madrigal JA, Emery VC, Morte C, Grace S, Koh MB, Potter M, Prentice HG, Dodi IA, Travers PJ. (2001) 'Cytomegalovirus-specific cellular immune responses and viremia in recipients of allogeneic stem cell transplants.'. J Infect Dis, United States: 184 (8), pp. 955-963.
  • Whalley SA, Murray JM, Brown D, Webster GJ, Emery VC, Dusheiko GM, Perelson AS. (2001) 'Kinetics of acute hepatitis B virus infection in humans.'. J Exp Med, United States: 193 (7), pp. 847-854.
  • Emery VC, Griffiths PD. (2000) 'Prediction of cytomegalovirus load and resistance patterns after antiviral chemotherapy.'. Proc Natl Acad Sci U S A, UNITED STATES: 97 (14), pp. 8039-8044.
  • Emery VC, Sabin CA, Cope AV, Gor D, Hassan-Walker AF, Griffiths PD. (2000) 'Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation.'. Lancet, ENGLAND: 355 (9220), pp. 2032-2036.
  • Emery VC, Cope AV, Bowen EF, Gor D, Griffiths PD. (1999) 'The dynamics of human cytomegalovirus replication in vivo.'. J Exp Med, UNITED STATES: 190 (2), pp. 177-182.
  • Cope AV, Sabin C, Burroughs A, Rolles K, Griffiths PD, Emery VC. (1997) 'Interrelationships among quantity of human cytomegalovirus (HCMV) DNA in blood, donor-recipient serostatus, and administration of methylprednisolone as risk factors for HCMV disease following liver transplantation.'. J Infect Dis, UNITED STATES: 176 (6), pp. 1484-1490.
  • Bowen EF, Sabin CA, Wilson P, Griffiths PD, Davey CC, Johnson MA, Emery VC. (1997) 'Cytomegalovirus (CMV) viraemia detected by polymerase chain reaction identifies a group of HIV-positive patients at high risk of CMV disease.'. AIDS, UNITED STATES: 11 (7), pp. 889-893.
  • Bowen EF, Wilson P, Cope A, Sabin C, Griffiths P, Davey C, Johnson M, Emery V. (1996) 'Cytomegalovirus retinitis in AIDS patients: influence of cytomegaloviral load on response to ganciclovir, time to recurrence and survival.'. AIDS, UNITED STATES: 10 (13), pp. 1515-1520.
  • Webster A, Lee CA, Cook DG, Grundy JE, Emery VC, Kernoff PB, Griffiths PD. (1989) 'Cytomegalovirus infection and progression towards AIDS in haemophiliacs with human immunodeficiency virus infection.'. Lancet, ENGLAND: 2 (8654), pp. 63-66.

Journal articles

  • Emery VC, Richardson BA, John-Stewart G, Atkinson C, Nduati R, Asbjornsdottir K, Boeckh M, Overbaugh J, Slyker JA. (2015) 'Vertical cytomegalovirus transmission from HIV-infected women randomized to formula feeding versus breastfeeding'. Oxford University Press Journal of Infectious Diseases,

    Abstract

    Background. Cytomegalovirus (CMV) is associated with morbidity and mortality in human immunodeficiency virus (HIV)–exposed infants. We assessed the effect of and relative contribution of breastfeeding to CMV acquisition among infants delivered by HIV-infected mothers. Methods. Between 1993 and 1998 pregnant, HIV-infected women in Nairobi, Kenya, were randomly assigned to breastfeed or formula-feed their infants in an HIV transmission study. Women were allocated equally between treatment arms, and the study was not blinded. The primary endpoint of this nested study was time to infant CMV infection. Results. CMV infection was assessed in 138 breastfed and 134 formula-fed infants. Baseline characteristics were similar between arms. Breastfed infants acquired CMV earlier than formula-fed infants (median age of acquisition, 4.26 vs 9.87 months; P < .001) and had a higher 1-year probability of CMV infection (0.89 vs 0.69; P < .001). Breastfeeding was associated with a 1.6-fold increased risk of infant CMV acquisition independent of infant HIV status (multivariable hazard ratio, 1.61; 95% confidence interval, 1.20–2.16; P = .002). Approximately one third of CMV infections occurred during the peripartum period, with 40% acquired through breastfeeding and the remainder acquired through modes other than breast milk.

  • Nejati A, Shoja Z, Shahmahmoodi S, Tafakhori A, Mollaei-Kandelous Y, Rezaei F, Hamid KM, Mirshafiey A, Doosti R, Sahraian MA, Mahmoudi M, Shokri F, Emery V, Marashi SM. (2015) 'EBV and vitamin D status in relapsing-remitting multiple sclerosis patients with a unique cytokine signature'. Medical Microbiology and Immunology,
    [ Status: Accepted ]
  • Aldridge RW, Mattes FM, Rolando N, Rolles K, Smith C, Shirling G, Atkinson C, Burroughs AK, Milne RSB, Emery VC, Griffiths PD. (2015) 'Effects of donor/recipient human leukocyte antigen mismatch on human cytomegalovirus replication following liver transplantation'. Transplant Infectious Disease, 17 (1), pp. 25-32.
  • Emery VC. (2015) 'Restimulating interest in cytomegalovirus as a cofactor for HIV infection'. Journal of Infectious Diseases, 211 (2), pp. 169-171.
  • Van Damme E, Sauviller S, Lau B, Kesteleyn B, Griffiths P, Burroughs A, Emery V, Sinclair J, Van Loock M. (2015) 'Glucocorticosteroids trigger reactivation of human cytomegalovirus from latently infected myeloid cells and increase the risk for HCMV infection in D+R+ liver transplant patients'. Journal of General Virology, 96 (1), pp. 131-143.
  • Sims S, Colston J, Emery V, Klenerman P. (2014) 'CD73 is dispensable for the regulation of inflationary CD8+ T-cells after murine cytomegalovirus infection and adenovirus immunisation'. PLoS ONE, 9 (12)
  • Slyker J, Farquhar C, Atkinson C, Ásbjörnsdóttir K, Roxby A, Drake A, Kiarie J, Wald A, Boeckh M, Richardson B, Odem-Davis K, John-Stewart G, Emery V. (2014) 'Compartmentalized cytomegalovirus replication and transmission in the setting of maternal HIV-1 infection'. Clinical Infectious Diseases, 58 (4), pp. 564-572.
  • Roxby AC, Atkinson C, Ásbjörnsdóttir K, Farquhar C, Kiarie JN, Drake AL, Wald A, Boeckh M, Richardson B, Emery V, John-Stewart G, Slyker JA. (2014) 'Maternal valacyclovir and infant cytomegalovirus acquisition: A randomized controlled trial among HIV-infected women'. PLoS ONE, 9 (2)
  • Atkinson C, Emery VC, Griffiths PD. (2014) 'Development of a novel single tube nested PCR for enhanced detection of cytomegalovirus DNA from dried blood spots'. Journal of Virological Methods, 196, pp. 40-44.
  • Griffiths PD, Emery VC. (2014) 'Taming the transplantation troll by targeting terminase'. New England Journal of Medicine, 370 (19), pp. 1844-1846.
  • Emery V, Zuckerman M, Jackson G, Aitken C, Osman H, Pagliuca A, Potter M, Peggs K, Clark A. (2013) 'Management of cytomegalovirus infection in haemopoietic stem cell transplantation'. British Journal of Haematology, 162 (1), pp. 25-39.
  • Griffiths SJ, Riddell NE, Masters J, Libri V, Henson SM, Wertheimer A, Wallace D, Sims S, Rivino L, Larbi A, Kemeny DM, Nikolich-Zugich J, Kern F, Klenerman P, Emery VC, Akbar AN. (2013) 'Age-associated increase of low-avidity cytomegalovirus-specific CD8 + T cells that re-express CD45RA'. Journal of Immunology, 190 (11), pp. 5363-5372.
  • Emery VC. (2013) 'CMV infected or not CMV infected: That is the question'. European Journal of Immunology, 43 (4), pp. 886-888.
  • Brennan DC, Aguado JM, Potena L, Jardine AG, Legendre C, Säemann MD, Mueller NJ, Merville P, Emery V, Nashan B. (2013) 'Effect of maintenance immunosuppressive drugs on virus pathobiology: Evidence and potential mechanisms'. Reviews in Medical Virology, 23 (2), pp. 97-125.
  • Emery VC. (2013) 'Human herpesvirus vaccines and future directions.'. Am J Transplant, United States: 13 Suppl 3, pp. 79-86.
  • Manicklal S, Emery VC, Lazzarotto T, Boppana SB, Gupta RK. (2013) 'The "Silent" global burden of congenital cytomegalovirus'. Clinical Microbiology Reviews, 26 (1), pp. 86-102.
  • Emery V, Zuckerman M, Jackson G, Aitken C, Osman H, Pagliuca A, Potter M, Peggs K, Clark A. (2013) 'Management of cytomegalovirus infection in haemopoietic stem cell transplantation'. British Journal of Haematology,
  • Atabani SF, Emery VC, Smith C, Harber M, Thorburn D, Griffiths PD. (2012) 'Response to letter regarding "cytomegalovirus replication kinetics in solid organ transplant recipients managed by preemptive therapy".'. Am J Transplant, United States: 12 (10), pp. 2859-2860.
  • Atabani SF, Smith C, Atkinson C, Aldridge RW, Rodriguez-Perálvarez M, Rolando N, Harber M, Jones G, O'Riordan A, Burroughs AK, Thorburn D, O'Beirne J, Milne RSB, Emery VC, Griffiths PD. (2012) 'Cytomegalovirus replication kinetics in solid organ transplant recipients managed by preemptive therapy'. American Journal of Transplantation, 12 (9), pp. 2457-2464.
  • Nashan B, Gaston R, Emery V, Säemann MD, Mueller NJ, Couzi L, Dantal J, Shihab F, Mulgaonkar S, Seun Kim Y, Brennan DC. (2012) 'Review of cytomegalovirus infection findings with mammalian target of rapamycin inhibitor-based immunosuppressive therapy in de novo renal transplant recipients'. Transplantation, 93 (11), pp. 1075-1085.
  • Emery VC, Asher K, Sanjuan CDEJ. (2012) 'Importance of the cytomegalovirus seropositive recipient as a contributor to disease burden after solid organ transplantation.'. J Clin Virol, Netherlands: 54 (2), pp. 125-129.
  • Atabani SF, Smith C, Atkinson C, Aldridge RW, Rodriguez-Perálvarez M, Rolando N, Harber M, Jones G, O'Riordan A, Burroughs AK, Thorburn D, O'Beirne J, Milne RS, Emery VC, Griffiths PD. (2012) 'Cytomegalovirus replication kinetics in solid organ transplant recipients managed by preemptive therapy.'. Am J Transplant, United States: 12 (9), pp. 2457-2464.
  • Marashi SM, Raeiszadeh M, Enright V, Tahami F, Workman S, Chee R, Webster AD, Milne RS, Emery VC. (2012) 'Influence of cytomegalovirus infection on immune cell phenotypes in patients with common variable immunodeficiency.'. J Allergy Clin Immunol, United States: 129 (5), pp. 1349-1356.e3.
  • Emery VC. (2012) 'Cytomegalovirus: recent progress in understanding pathogenesis and control.'. QJM, England: 105 (5), pp. 401-405.
  • Emery VC, Manuel O, Asberg A, Pang X, Kumar D, Hartmann A, Preiksaitis JK, Pescovitz MD, Rollag H, Jardine AG, Gahlemann CG, Humar A. (2012) 'Differential decay kinetics of human cytomegalovirus glycoprotein B genotypes following antiviral chemotherapy'. ELSEVIER SCIENCE BV JOURNAL OF CLINICAL VIROLOGY, 54 (1), pp. 56-60.
  • Emery VC, Mattes FM. (2012) 'Pre-emptive therapy for the management of cytomegalovirus disease after transplantation'. , pp. 193-202.
  • Brennan DC, Aguado JM, Potena L, Jardine AG, Legendre C, Säemann MD, Mueller NJ, Merville P, Emery V, Nashan B. (2012) 'Effect of maintenance immunosuppressive drugs on virus pathobiology: Evidence and potential mechanisms'. Reviews in Medical Virology,
  • Andrews PA, Emery VC, Newstead C. (2011) 'Summary of the British Transplantation Society Guidelines for the Prevention and Management of CMV Disease After Solid Organ Transplantation.'. Transplantation, United States: 92 (11), pp. 1181-1187.
  • Atabani SF, Atkinson C, Aldridge RW, Smith C, Harber M, Thornbun D, Rolando N, Emery VC, Griffiths PD. (2011) 'A QUANTITATIVE ANALYSIS OF CMV INFECTION IN SOLID-ORGAN TRANSPLANT RECIPIENTS MANAGED EXCLUSIVELY ON PRE-EMPTIVE THERAPY'. WILEY-BLACKWELL TRANSPLANT INTERNATIONAL, 24, pp. 175-175.
  • Atkinson C, Emery VC. (2011) 'Cytomegalovirus quantification: where to next in optimising patient management?'. J Clin Virol, Netherlands: 51 (4), pp. 223-228.
  • Emery VC. (2011) 'Could a vaccine against immune-evading cytomegalovirus become a reality?'. EXPERT REVIEWS EXPERT REVIEW OF VACCINES, 10 (8), pp. 1109-1111.
  • Marashi SM, Raeiszadeh M, Workman S, Rahbar A, Soderberg-Naucler C, Klenerman P, Chee R, Webster AD, Milne RS, Emery VC. (2011) 'Inflammation in common variable immunodeficiency is associated with a distinct CD8(+) response to cytomegalovirus.'. J Allergy Clin Immunol, United States: 127 (6), pp. 1385-93.e4.
  • Emery VC, Milne RSB. (2011) 'Recent developments in antiviral drugs for cytomegalovirus'. FUTURE MEDICINE LTD FUTURE VIROLOGY, 6 (5), pp. 633-651.
  • Griffiths PD, Stanton A, McCarrell E, Smith C, Osman M, Harber M, Davenport A, Jones G, Wheeler DC, O'Beirne J, Thorburn D, Patch D, Atkinson CE, Pichon S, Sweny P, Lanzman M, Woodford E, Rothwell E, Old N, Kinyanjui R, Haque T, Atabani S, Luck S, Prideaux S, Milne RS, Emery VC, Burroughs AK. (2011) 'Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial.'. Lancet, England: 377 (9773), pp. 1256-1263.
  • Emery VC, Einsele H, Atabani S, Haque T. (2011) 'Immunotherapy and vaccination after transplant: the present, the future.'. Hematol Oncol Clin North Am, United States: 25 (1), pp. 215-229.
  • Carpenter B, Haque T, Dimopoulou M, Atkinson C, Roughton M, Grace S, Denovan S, Fielding A, Kottaridis PD, Griffiths P, Mackinnon S, Emery V, Chakraverty R. (2010) 'Incidence and dynamics of Epstein-Barr virus reactivation after alemtuzumab-based conditioning for allogeneic hematopoietic stem-cell transplantation.'. Transplantation, United States: 90 (5), pp. 564-570.
  • Buyck HC, Griffiths PD, Emery VC. (2010) 'Human cytomegalovirus (HCMV) replication kinetics in stem cell transplant recipients following anti-HCMV therapy.'. J Clin Virol, Netherlands: 49 (1), pp. 32-36.
  • Buyck HC, Prentice HG, Griffiths PD, Emery VC. (2010) 'The risk of early and late CMV DNAemia associated with Campath use in stem cell transplant recipients.'. Bone Marrow Transplant, England: 45 (7), pp. 1212-1219.
  • Parker A, Bowles K, Bradley JA, Emery V, Featherstone C, Gupte G, Marcus R, Parameshwar J, Ramsay A, Newstead C. (2010) 'Diagnosis of post-transplant lymphoproliferative disorder in solid organ transplant recipients - BCSH and BTS Guidelines'. WILEY-BLACKWELL BRITISH JOURNAL OF HAEMATOLOGY, 149 (5), pp. 675-692.
  • Parker A, Bowles K, Bradley JA, Emery V, Featherstone C, Gupte G, Marcus R, Parameshwar J, Ramsay A, Newstead C. (2010) 'Management of post-transplant lymphoproliferative disorder in adult solid organ transplant recipients - BCSH and BTS Guidelines'. WILEY-BLACKWELL BRITISH JOURNAL OF HAEMATOLOGY, 149 (5), pp. 693-705.
  • Emery VC, Einsele H, Atabani S, Haque T. (2010) 'Immunotherapy and vaccination after transplant: the present, the future.'. Infect Dis Clin North Am, United States: 24 (2), pp. 515-529.
  • Dargan DJ, Douglas E, Cunningham C, Jamieson F, Stanton RJ, Baluchova K, McSharry BP, Tomasec P, Emery VC, Percivalle E, Sarasini A, Gerna G, Wilkinson GWG, Davison AJ. (2010) 'Sequential mutations associated with adaptation of human cytomegalovirus to growth in cell culture'. SOC GENERAL MICROBIOLOGY JOURNAL OF GENERAL VIROLOGY, 91, pp. 1535-1546.
  • Walton JA, Lydyard PM, Nathwani A, Emery V, Akbar A, Glennie MJ, Porakishvili N. (2010) 'Patients with B cell chronic lymphocytic leukaemia have an expanded population of CD4+perforin expressing T cells enriched for human cytomegalovirus specificity and an effector-memory phenotype'. WILEY-BLACKWELL PUBLISHING, INC BRITISH JOURNAL OF HAEMATOLOGY, 148 (2), pp. 274-284.
  • Shannon-Lowe CD, Emery VC. (2010) 'The effects of maribavir on the autophosphorylation of ganciclovir resistant mutants of the cytomegalovirus UL97 protein.'. Herpesviridae, England: 1 (1)
  • Li YT, Emery VC, Surah S, Jarmulowicz M, Sweny P, Kidd IM, Griffiths PD, Clark DA. (2010) 'Extensive Human Cytomegalovirus (HCMV) Genomic DNA in the Renal Tubular Epithelium Early After Renal Transplantation: Relationship With HCMV DNAemia and Long-Term Graft Function'. WILEY-LISS JOURNAL OF MEDICAL VIROLOGY, 82 (1), pp. 85-93.
  • Kopycinski J, Osman M, Griffiths PD, Emery VC. (2010) 'Sequence flexibility of the immunodominant HLA A*0201 restricted ppUL83 CD8 T-cell epitope of human cytomegalovirus.'. J Med Virol, United States: 82 (1), pp. 94-103.
  • Slyker JA, Lohman-Payne BL, John-Stewart GC, Maleche-Obimbo E, Emery S, Richardson B, Dong T, Iversen AKN, Mbori-Ngacha D, Overbaugh J, Emery VC, Rowland-Jones SL. (2009) 'Acute cytomegalovirus infection in Kenyan HIV-infected infants'. LIPPINCOTT WILLIAMS & WILKINS AIDS, 23 (16), pp. 2173-2181.
  • Manuel O, Asberg A, Pang X, Rollag H, Emery VC, Preiksaitis JK, Kumar D, Pescovitz MD, Bignamini AA, Hartmann A, Jardine AG, Humar A. (2009) 'Impact of Genetic Polymorphisms in Cytomegalovirus Glycoprotein B on Outcomes in Solid-Organ Transplant Recipients with Cytomegalovirus Disease'. UNIV CHICAGO PRESS CLINICAL INFECTIOUS DISEASES, 49 (8), pp. 1160-1166.
  • Slyker JA, Lohman-Payne BL, Rowland-Jones SL, Otieno P, Maleche-Obimbo E, Richardson B, Farquhar C, Mbori-Ngacha D, Emery VC, John-Stewart GC. (2009) 'The detection of cytomegalovirus DNA in maternal plasma is associated with mortality in HIV-1-infected women and their infants'. LIPPINCOTT WILLIAMS & WILKINS AIDS, 23 (1), pp. 117-124.
  • Nebbia G, Mattes FM, Smith C, Hainsworth E, Kopycinski J, Burroughs A, Griffiths PD, Klenerman P, Emery VC. (2008) 'Polyfunctional cytomegalovirus-specific CD4+ and pp65 CD8+ T cells protect against high-level replication after liver transplantation.'. Am J Transplant, Denmark: 8 (12), pp. 2590-2599.
  • Bradley AJ, Kovacs IJ, Gatherer D, Dargan DJ, Alkharsah KR, Chan PKS, Carman WF, Dedicoat M, Emery VC, Geddes CC, Gerna G, Ben-Ismaeil B, Kaye S, McGregor A, Moss PA, Pusztai R, Rawlinson WD, Scott GM, Wilkinson GWG, Schulz TF, Davison AJ. (2008) 'Genotypic analysis of two hypervariable human cytomegalovirus genes'. WILEY-LISS JOURNAL OF MEDICAL VIROLOGY, 80 (9), pp. 1615-1623.
  • Walter S, Atkinson C, Sharland M, Rice P, Raglan E, Emery VC, Griffiths PD. (2008) 'Congenital cytornegalovirus: association between dried blood spot viral load and hearing loss'. B M J PUBLISHING GROUP ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 93 (4), pp. F280-F285.
  • Danta M, Semmo N, Fabris P, Brown D, Pybus OG, Sabin CA, Bhagani S, Emery VC, Dusheiko GM, Klenerman P. (2008) 'Impact of HIV on host-virus interactions during early hepatitis C virus infection.'. J Infect Dis, United States: 197 (11), pp. 1558-1566.
  • Mattes FM, Vargas A, Kopycinski J, Hainsworth EG, Sweny P, Nebbia G, Bazeos A, Lowdell M, Klenerman P, Phillips RE, Griffiths PD, Emery VC. (2008) 'Functional impairment of cytomegalovirus specific CD8 T cells predicts high-level replication after renal transplantation.'. Am J Transplant, Denmark: 8 (5), pp. 990-999.
  • Fraile-Ramos A, Pelchen-Matthews A, Risco C, Rejas MT, Emery VC, Hassan-Walker AF, Esteban M, Marsh M. (2007) 'The ESCRT machinery is not required for human cytomegalovirus envelopment'. WILEY-BLACKWELL CELLULAR MICROBIOLOGY, 9 (12), pp. 2955-2967.
  • Fraile-Ramos A, Pelchen-Matthews A, Risco C, Rejas MT, Emery VC, Hassan-Walker AF, Esteban M, Marsh M. (2007) 'The ESCRT machinery is not required for human cytomegalovirus envelopment'. Cellular Microbiology, 9 (12), pp. 2955-2967.
  • Emery V. (2007) 'Facing the facts: The indirect effects of cytomegalovirus'. LIPPINCOTT WILLIAMS & WILKINS TRANSPLANTATION, 84 (6), pp. S7-S10.
  • Nebbia G, Mattes FM, Sabin CA, Samonakis D, Rolando N, Burroughs AK, Emery VC. (2007) 'Differential effects of prednisolone and azathioprine on the development of human cytomegalovirus replication post liver transplantation.'. Transplantation, United States: 84 (5), pp. 605-610.
  • Fishman JA, Emery V, Freeman R, Pascual M, Rostaing L, Schlitt HJ, Sgarabotto D, Torre-Cisneros J, Uknis ME. (2007) 'Cytomegalovirus in transplantation - challenging the status quo'. WILEY-BLACKWELL PUBLISHING, INC CLINICAL TRANSPLANTATION, 21 (2), pp. 149-158.
  • Nebbia G, Mattes FM, Cholongitas E, Garcia-Diaz A, Samonakis DN, Burroughs AK, Emery VC. (2007) 'Exploring the bidirectional interactions between human cytomegalovirus and hepatitis C virus replication after liver transplantation.'. Liver Transpl, United States: 13 (1), pp. 130-135.
  • Emery VC, Clark DA. (2007) 'HHV-6A, 6B, and 7: Persistence in the population, epidemiology and transmission'. , pp. 875-882.
  • Paradowska E, Przepiorkiewicz M, Nowakowska D, Studzinska M, Wilczynski J, Emery VC, Lesnikowski ZJ. (2006) 'Detection of cytomegalovirus in human placental cells by polymerase chain reaction'. WILEY-BLACKWELL PUBLISHING, INC APMIS, 114 (11), pp. 764-771.
  • Raeiszadeh M, Kopycinski J, Paston SJ, Diss T, Lowdell M, Hardy GA, Hislop AD, Workman S, Dodi A, Emery V, Webster AD. (2006) 'The T cell response to persistent herpes virus infections in common variable immunodeficiency.'. Clin Exp Immunol, England: 146 (2), pp. 234-242.
  • Regoes RR, Bowen EF, Cope AV, Gor D, Hassan-Walker AF, Prentice HG, Johnson MA, Sweny P, Burroughs AK, Griffiths PD, Bonhoeffer S, Emery VC. (2006) 'Modelling cytomegalovirus replication patterns in the human host: factors important for pathogenesis'. ROYAL SOC PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 273 (1596), pp. 1961-1967.
  • Caplin B, Sweny P, Burroughs A, Emery V, Griffiths P. (2005) 'Antiviral treatment after solid organ transplantation'. ELSEVIER SCIENCE INC LANCET, 366 (9488), pp. 806-807.
  • Samonakis DN, Triantos CK, Thalheimer U, Quaglia A, Leandro G, Teixeira R, Papatheodoridis GV, Sabin CA, Rolando N, Davies S, Dhillon AP, Griffiths P, Emery V, Patch DW, Davidson BR, Rolles K, Burroughs AK. (2005) 'Immunosuppression and donor age with respect to severity of HCV recurrence after liver transplantation.'. Liver Transpl, United States: 11 (4), pp. 386-395.
  • Mattes FM, Hainsworth EG, Hassan-Walker AF, Burroughs AK, Sweny P, Griffiths PD, Emery VC. (2005) 'Kinetics of cytomegalovirus load decrease in solid-organ transplant recipients after preemptive therapy with valganciclovir.'. J Infect Dis, United States: 191 (1), pp. 89-92.
  • Caplin B, Sweny P, Burroughs A, Emery V, Griffiths P, Hodson EM, Jones CA, Webster AC, Strippoli GFM, Craig JC. (2005) 'Antiviral treatment after solid organ transplantation [5] (multiple letters)'. Lancet, 366 (9488), pp. 806-807.
  • Razonable RR, Emery VC. (2004) 'Management of CMV infection and disease in transplant patients'. Herpes, 11 (3), pp. 77-86.
  • Hassan-Walker AF, Okwuadi S, Lee L, Griffiths PD, Emery VC. (2004) 'Sequence variability of the alpha-chemokine UL146 from clinical strains of human cytomegalovirus.'. J Med Virol, United States: 74 (4), pp. 573-579.
  • Whalley SA, Brown D, Webster GJ, Jacobs R, Reignat S, Bertoletti A, Teo CG, Emery V, Dusheiko GM. (2004) 'Evolution of hepatitis B virus during primary infection in humans: transient generation of cytotoxic T-cell mutants.'. Gastroenterology, United States: 127 (4), pp. 1131-1138.
  • Deayton JR, Prof Sabin CA, Johnson MA, Emery VC, Wilson P, Griffiths PD. (2004) 'Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy.'. Lancet, England: 363 (9427), pp. 2116-2121.
  • Fryer JF, Griffiths PD, Emery VC, Clark DA. (2004) 'Susceptibility of porcine cytomegalovirus to antiviral drugs.'. J Antimicrob Chemother, England: 53 (6), pp. 975-980.
  • Dolan A, Cunningham C, Hector RD, Hassan-Walker AF, Lee L, Addison C, Dargan DJ, McGeoch DJ, Gatherer D, Emery VC, Griffiths PD, Sinzger C, McSharry BP, Wilkinson GWG, Davison AJ. (2004) 'Genetic content of wild-type human cytomegalovirus'. SOC GENERAL MICROBIOLOGY JOURNAL OF GENERAL VIROLOGY, 85, pp. 1301-1312.
  • Mattes FM, Hainsworth EG, Geretti AM, Nebbia G, Prentice G, Potter M, Burroughs AK, Sweny P, Hassan-Walker AF, Okwuadi S, Sabin C, Amooty G, Brown VS, Grace SC, Emery VC, Griffiths PD. (2004) 'A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients.'. J Infect Dis, United States: 189 (8), pp. 1355-1361.
  • Herrero-Martínez E, Sabin CA, Lee CA, Jones IM, Pillay D, Emery VC. (2004) 'The effect of highly active antiretroviral therapy for HIV on the anti-HCV specific humoral immune response.'. J Med Virol, United States: 72 (2), pp. 187-193.
  • Papagno L, Spina CA, Marchant A, Salio M, Rufer N, Little S, Dong T, Chesney G, Waters A, Easterbrook P, Dunbar PR, Shepherd D, Cerundolo V, Emery V, Griffiths P, Conlon C, McMichael AJ, Richman DD, Rowland-Jones SL, Appay V. (2004) 'Immune activation and CD8(+) T-cell differentiation towards senescence in HIV-1 infection'. PUBLIC LIBRARY SCIENCE PLOS BIOLOGY, 2 (2) Article number ARTN e20 , pp. 173-185.
  • Grahame-Clarke C, Chan NN, Andrew D, Ridgway GL, Betteridge DJ, Emery V, Colhoun HM, Vallance P. (2003) 'Human cytomegalovirus seropositivity is associated with impaired vascular function.'. Circulation, United States: 108 (6), pp. 678-683.
  • Temperton NJ, Quenelle DC, Lawson KM, Zuckerman JN, Kern ER, Griffiths PD, Emery VC. (2003) 'Enhancement of humoral immune responses to a human cytomegalovirus DNA vaccine: adjuvant effects of aluminum phosphate and CpG oligodeoxynucleotides.'. J Med Virol, United States: 70 (1), pp. 86-90.
  • Akter P, Cunningham C, McSharry BP, Dolan A, Addison C, Dargan DJ, Hassan-Walker AF, Emery VC, Griffiths PD, Wilkinson GWG, Davison AJ. (2003) 'Two novel spliced genes in human cytomegalovirus'. SOC GENERAL MICROBIOLOGY JOURNAL OF GENERAL VIROLOGY, 84, pp. 1117-1122.
  • Clark DA, Emery VC, Griffiths PD. (2003) 'Cytomegalovirus, human herpesvirus-6, and human herpesvirus-7 in hematological patients'. Seminars in Hematology, 40 (2), pp. 154-162.
  • Clark DA, Emery VC, Griffiths PD. (2003) 'Cytomegalovirus, human herpesvirus-6, and human herpesvirus-7 in hematological patients.'. Semin Hematol, United States: 40 (2), pp. 154-162.
  • Clark DA, Fryer JF, Tucker AW, McArdle PD, Hughes AE, Emery VC, Griffiths PD. (2003) 'Porcine cytomegalovirus in pigs being bred for xenograft organs: progress towards control.'. Xenotransplantation, Denmark: 10 (2), pp. 142-148.
  • Davison AJ, Akter P, Cunningham C, Dolan A, Addison C, Dargan DJ, Hassan-Walker AF, Emery VC, Griffiths PD, Wilkinson GWG. (2003) 'Homology between the human cytomegalovirus PL11 gene family and human adenovirus E3 genes'. SOC GENERAL MICROBIOLOGY JOURNAL OF GENERAL VIROLOGY, 84, pp. 657-663.
  • Sabin CA, Griffioen A, Yee TT, Emery VC, Herrero-Martinez E, Phillips AN, Lee CA. (2002) 'Markers of HIV-1 disease progression in individuals with haemophilia coinfected with hepatitis C virus: a longitudinal study.'. Lancet, England: 360 (9345), pp. 1546-1551.
  • Deayton JR, Sabin CA, Britt WB, Jones IM, Wilson P, Johnson MA, Griffiths PD, Emery VC. (2002) 'Rapid reconstitution of humoral immunity against cytomegalovirus but not HIV following highly active antiretroviral therapy.'. AIDS, England: 16 (16), pp. 2129-2135.
  • Sabin CA, Emery V, Devereux HL, Griffioen A, Bishop J, Dusheiko G, Yee TT, Herrero-Martinez E, Lee CA. (2002) 'Long-term patterns of hepatitis C virus RNA concentrations in a cohort of HIV seronegative men with bleeding disorders.'. J Med Virol, United States: 68 (1), pp. 68-75.
  • Leśnikowski ZJ, Paradowska E, Przepiórkiewicz M, Olejniczak A, Emery VC. (2002) '[Drugs against human cytomegalovirus].'. Pol Merkur Lekarski, Poland: 13 (75), pp. 242-249.
  • Herrero-Martínez E, Sabin CA, Evans JG, Griffioen A, Lee CA, Emery VC. (2002) 'The prognostic value of a single hepatitis C virus RNA load measurement taken early after human immunodeficiency virus seroconversion.'. J Infect Dis, United States: 186 (4), pp. 470-476.
  • Pillay D, Emery VC, Mutimer D, Ogilvie MM, Carman W, Mutton K, Wreghitt T, Westmoreland D, Breuer J, Zuckerman M. (2002) 'Guidelines for laboratory monitoring of treatment of persistent virus infections'. ELSEVIER SCIENCE BV JOURNAL OF CLINICAL VIROLOGY, 25 (1) Article number PII S1386-6532(02)00018-5 , pp. 73-92.
  • Emery VC. (2002) 'Expert comments: Diagnostic value of enzyme linked immuno-sorbent assay'. Journal of Postgraduate Medicine, 48 (3)
  • Emery VC, Hassan-Walker AF, Burroughs AK, Griffiths PD. (2002) 'Human cytomegalovirus (HCMV) replication dynamics in HCMV-naive and -experienced immunocompromised hosts.'. J Infect Dis, United States: 185 (12), pp. 1723-1728.
  • Nokta MA, Holland F, De Gruttola V, Emery VC, Jacobson MA, Griffiths P, Pollard RB, Feinberg JE. (2002) 'Cytomegalovirus (CMV) polymerase chain reaction profiles in individuals with advanced human immunodeficiency virus infection: Relationship to CMV disease'. OXFORD UNIV PRESS INC JOURNAL OF INFECTIOUS DISEASES, 185 (12), pp. 1717-1722.
  • Whalley SA, Brown D, Webster GJM, Jacobs R, Teo CG, Emery VC, Dusheiko GM. (2002) 'Evolution of hepatitis B virus during primary infection'. BRITISH MED JOURNAL PUBL GROUP GUT, 50, pp. A118-A118.
  • Whalley SA, Webster GJM, Brown D, Teo CG, Bertoletti A, Emery VC, Dusheiko GM. (2002) 'Transient generation of core CD8+ cytotoxic T-cell escape mutants during primary HBV infection'. B M J PUBLISHING GROUP GUT, 50, pp. A112-A112.
  • Whalley S, Brown D, Webster G, Jacobs R, Teo CG, Emery V, Dusheiko G. (2002) 'Evolution of hepatitis B virus during primary infection: Relevance to virulence and outcome'. ELSEVIER SCIENCE BV JOURNAL OF HEPATOLOGY, 36, pp. 95-95.
  • Lock MJ, Thorley N, Teo J, Emery VC. (2002) 'Azidodeoxythymidine and didehydrodeoxythymidine as inhibitors and substrates of the human herpesvirus 8 thymidine kinase.'. J Antimicrob Chemother, England: 49 (2), pp. 359-366.
  • Emery VC, Hassan-Walker AF. (2002) 'Focus on new drugs in development against human cytomegalovirus.'. Drugs, New Zealand: 62 (13), pp. 1853-1858.
  • Prentice HG, Potter MN, Mattes FM, Hainsworth E, Murdin-Geretti A, Nebbia G, Burroughs AK, Sweeny P, Hassan-Walker AF, Okwuadi S, Emery VC, Griffiths PD. (2001) 'A randomized, controlled trial comparing ganciclovir or ganciclovir plus foscarnet (each at half dose) for pre-emptive therapy of cytomegalovirus infection in transplant recipients.'. AMER SOC HEMATOLOGY BLOOD, 98 (11), pp. 395A-395A.
  • Drew WL, Paya CV, Emery V. (2001) 'Cytomegalovirus (CMV) resistance to antivirals'. WILEY-BLACKWELL AMERICAN JOURNAL OF TRANSPLANTATION, 1 (4), pp. 307-312.
  • Aubert G, Hassan-Walker AF, Madrigal JA, Emery VC, Morte C, Grace S, Koh MB, Potter M, Prentice HG, Dodi IA, Travers PJ. (2001) 'Cytomegalovirus-specific cellular immune responses and viremia in recipients of allogeneic stem cell transplants.'. J Infect Dis, United States: 184 (8), pp. 955-963.
  • Devereux HL, Emery VC, Johnson MA, Loveday C. (2001) 'Replicative fitness in vivo of HIV-1 variants with multiple drug resistance-associated mutations.'. J Med Virol, United States: 65 (2), pp. 218-224.
  • Fryer J, Tucker D, Hughes A, Emery V, Griffiths P, Clark D. (2001) 'Porcine cytomegalovirus in pigs being bred for xenograft organs: prospects for eradication'. WILEY-BLACKWELL XENOTRANSPLANTATION, 8, pp. 15-15.
  • Hassan-Walker AF, Mattes FM, Griffiths PD, Emery VC. (2001) 'Quantity of cytomegalovirus DNA in different leukocyte populations during active infection in vivo and the presence of gB and UL18 transcripts.'. J Med Virol, United States: 64 (3), pp. 283-289.
  • Emery VC. (2001) 'Progress in understanding cytomegalovirus drug resistance.'. J Clin Virol, Netherlands: 21 (3), pp. 223-228.
  • Emery VC. (2001) 'Human herpesviruses 6 and 7 in solid organ transplant recipients.'. Clin Infect Dis, United States: 32 (9), pp. 1357-1360.
  • Whalley SA, Murray JM, Brown D, Webster GJ, Emery VC, Dusheiko GM, Perelson AS. (2001) 'Kinetics of acute hepatitis B virus infection in humans.'. J Exp Med, United States: 193 (7), pp. 847-854.
  • Hassan-Walker AF, Vargas Cuero AL, Mattes FM, Klenerman P, Lechner F, Burroughs AK, Griffiths PD, Phillips RE, Emery VC. (2001) 'CD8+ cytotoxic lymphocyte responses against cytomegalovirus after liver transplantation: correlation with time from transplant to receipt of tacrolimus.'. J Infect Dis, United States: 183 (6), pp. 835-843.
  • Emery VC. (2001) 'Prophylaxis for CMV should not now replace pre-emptive therapy in solid organ transplantation.'. Rev Med Virol, England: 11 (2), pp. 83-86.
  • Fryer JF, Griffiths PD, Fishman JA, Emery VC, Clark DA. (2001) 'Quantitation of porcine cytomegalovirus in pig tissues by PCR.'. J Clin Microbiol, United States: 39 (3), pp. 1155-1156.
  • Emery VC. (2001) 'Investigation of CMV disease in immunocompromised patients.'. J Clin Pathol, England: 54 (2), pp. 84-88.
  • Griffiths PD, McLean A, Emery VC. (2001) 'Encouraging prospects for immunisation against primary cytomegalovirus infection.'. Vaccine, England: 19 (11-12), pp. 1356-1362.
  • Emery VC. (2001) 'Cytomegalovirus and the aging population.'. Drugs Aging, New Zealand: 18 (12), pp. 927-933.
  • Emery VC, Cope AV, Sabin CA, Burroughs AK, Rolles K, Lazzarotto T, Landini MP, Brojanac S, Wise J, Maine GT. (2000) 'Relationship between IgM antibody to human cytomegalovirus, virus load, donor and recipient serostatus, and administration of methylprednisolone as risk factors for cytomegalovirus disease after liver transplantation.'. J Infect Dis, UNITED STATES: 182 (6), pp. 1610-1615.
  • Ljungman P, Wang FZ, Clark DA, Emery VC, Remberger M, Ringden O, Linde A. (2000) 'High levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patients'. WILEY-BLACKWELL BRITISH JOURNAL OF HAEMATOLOGY, 111 (3), pp. 774-781.
  • Teixeira R, Pastacaldi S, Davies S, Dhillon AP, Emery VC, Rolles K, Davidson B, Patch D, Burroughs AK. (2000) 'The influence of cytomegalovirus viraemia on the outcome of recurrent hepatitis C after liver transplantation.'. Transplantation, United States: 70 (10), pp. 1454-1458.
  • Emery VC. (2000) 'Viral-load kinetics in post-transplantation cytomegalovirus infections - Reply'. ELSEVIER SCIENCE INC LANCET, 356 (9242), pp. 1686-1686.
  • Stefanov R, Dimitrov BD, Emery VC. (2000) 'Viral-load kinetics in post-transplantation cytomegalovirus infections [6] (multiple letters)'. Lancet, 356 (9242), pp. 1685-1686.
  • Emery VC, Sabin CA, Hassan-Walker AF, Griffiths PD. (2000) 'Viral-load kinetics and CMV disease - Reply'. ELSEVIER SCIENCE INC LANCET, 356 (9238), pp. 1353-1353.
  • Kuo YH, Kuo YL, Emery VC, Sabin CA, Hassan-Walker AF, Griffiths PD. (2000) 'Viral-load kinetics and CMV disease [3] (multiple letters)'. Lancet, 356 (9238), pp. 1352-1353.
  • Deayton JR, Shannon-Lowe C, Wilson P, Johnson MA, Griffiths PD, Emery VC. (2000) 'Recurrence of CMV viraemia and development of anti-CMV drug resistance in patients receiving highly active antiretroviral therapy after CMV retinitis'. LIPPINCOTT WILLIAMS & WILKINS AIDS, 14, pp. S5-S6.
  • Deayton JR, Sabin CA, Johnson MA, Griffiths PD, Emery VC. (2000) 'Efficacy of the regenerating immune system in the inhibition of CMV replication after highly active antiretroviral therapy (HAART))'. LIPPINCOTT WILLIAMS & WILKINS AIDS, 14, pp. S5-S5.
  • Whalley SA, Murray JM, Brown D, Webster GJM, Emery VC, Dusheiko GH, Perelson AS. (2000) 'The kinetics of acute hepatitis B virus infection in humans.'. W B SAUNDERS CO HEPATOLOGY, 32 (4), pp. 446A-446A.
  • Mattes FM, McLaughlin JE, Emery VC, Clark DA, Griffiths PD. (2000) 'Histopathological detection of owl's eye inclusions is still specific for cytomegalovirus in the era of human herpesviruses 6 and 7.'. J Clin Pathol, ENGLAND: 53 (8), pp. 612-614.
  • Emery VC, Griffiths PD. (2000) 'Prediction of cytomegalovirus load and resistance patterns after antiviral chemotherapy.'. Proc Natl Acad Sci U S A, UNITED STATES: 97 (14), pp. 8039-8044.
  • Hassan-Walker AF, Vargas AL, Mattes FM, Klenerman P, Lechner F, Burroughs AK, Griffiths PD, Phillips RE, Emery VC. (2000) 'Immunosuppression for liver transplantation with tacrolimus impairs specific cytomegalovirus CD8 immune responses'. OXFORD UNIV PRESS INC CLINICAL INFECTIOUS DISEASES, 31 (1), pp. 317-317.
  • Deayton JR, Wilson P, Sabin CA, Davey CC, Johnson MA, Emery VC, Griffiths PD. (2000) 'Changes in the natural history of cytomegalovirus retinitis following the introduction of highly active antiretroviral therapy.'. AIDS, ENGLAND: 14 (9), pp. 1163-1170.
  • Emery VC. (2000) 'Tuning to the right frequency: cytotoxic T lymphocytes and cytomegalovirus.'. Transplantation, UNITED STATES: 69 (11), pp. 2241-2242.
  • Kidd IM, Clark DA, Sabin CA, Andrew D, Hassan-Walker AF, Sweny P, Griffiths PD, Emery VC. (2000) 'Prospective study of human betaherpesviruses after renal transplantation: association of human herpesvirus 7 and cytomegalovirus co-infection with cytomegalovirus disease and increased rejection.'. Transplantation, UNITED STATES: 69 (11), pp. 2400-2404.
  • Emery VC, Sabin CA, Cope AV, Gor D, Hassan-Walker AF, Griffiths PD. (2000) 'Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation.'. Lancet, ENGLAND: 355 (9220), pp. 2032-2036.
  • Kidd IM, Clark DA, Emery VC. (2000) 'A non-radioisotopic quantitative competitive polymerase chain reaction method: application in measurement of human herpesvirus 7 load.'. J Virol Methods, NETHERLANDS: 87 (1-2), pp. 177-181.
  • Sabin CA, Devereux HL, Clewley G, Emery VC, Phillips AN, Loveday C, Lee CA, Griffiths PD. (2000) 'Cytomegalovirus seropositivity and human immunodeficiency virus type 1 RNA levels in individuals with hemophilia.'. J Infect Dis, UNITED STATES: 181 (5), pp. 1800-1803.
  • Griffiths PD, Clark DA, Emery VC. (2000) 'Betaherpesviruses in transplant recipients.'. J Antimicrob Chemother, ENGLAND: 45 Suppl T3, pp. 29-34.
  • Griffiths PD, Ait-Khaled M, Bearcroft CP, Clark DA, Quaglia A, Davies SE, Burroughs AK, Rolles K, Kidd IM, Knight SN, Noibi SM, Cope AV, Phillips AN, Emery VC. (1999) 'Human herpesviruses 6 and 7 as potential pathogens after liver transplant: prospective comparison with the effect of cytomegalovirus.'. J Med Virol, UNITED STATES: 59 (4), pp. 496-501.
  • Grzywacz M, Deayton JR, Bowen EF, Wilson P, Emery VC, Johnson MA, Griffiths PD. (1999) 'Response of asymptomatic cytomegalovirus viraemia to oral ganciclovir 3 g/day or 6 g/day in HIV-infected patients.'. J Med Virol, UNITED STATES: 59 (3), pp. 323-328.
  • Emery VC, Sabin C, Feinberg JE, Grywacz M, Knight S, Griffiths PD. (1999) 'Quantitative effects of valacyclovir on the replication of cytomegalovirus (CMV) in persons with advanced human immunodeficiency virus disease: baseline CMV load dictates time to disease and survival. The AIDS Clinical Trials Group 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study Group.'. J Infect Dis, UNITED STATES: 180 (3), pp. 695-701.
  • Griffiths PD, Cope AV, Hassan-Walker AF, Emery VC. (1999) 'Diagnostic approaches to cytomegalovirus infection in bone marrow and organ transplantation.'. Transpl Infect Dis, Sweden: 1 (3), pp. 179-186.
  • Bowen EF, Cherrington JM, Lamy PD, Griffiths PD, Johnson MA, Emery VC. (1999) 'Quantitative changes in cytomegalovirus DNAemia and genetic analysis of the UL97 and UL54 genes in AIDS patients receiving cidofovir following ganciclovir therapy.'. J Med Virol, UNITED STATES: 58 (4), pp. 402-407.
  • Emery VC, Cope AV, Bowen EF, Gor D, Griffiths PD. (1999) 'The dynamics of human cytomegalovirus replication in vivo.'. J Exp Med, UNITED STATES: 190 (2), pp. 177-182.
  • Deayton J, Mocroft A, Wilson P, Emery VC, Johnson MA, Griffiths PD. (1999) 'Loss of cytomegalovirus (CMV) viraemia following highly active antiretroviral therapy in the absence of specific anti-CMV therapy.'. AIDS, ENGLAND: 13 (10), pp. 1203-1206.
  • Hassan-Walker AF, Kidd IM, Sabin C, Sweny P, Griffiths PD, Emery VC. (1999) 'Quantity of human cytomegalovirus (CMV) DNAemia as a risk factor for CMV disease in renal allograft recipients: relationship with donor/recipient CMV serostatus, receipt of augmented methylprednisolone and antithymocyte globulin (ATG).'. J Med Virol, UNITED STATES: 58 (2), pp. 182-187.
  • Ansari A, Emery VC. (1999) 'The U69 gene of human herpesvirus 6 encodes a protein kinase which can confer ganciclovir sensitivity to baculoviruses.'. J Virol, UNITED STATES: 73 (4), pp. 3284-3291.
  • Whalley SA, Brown D, Webster GJM, Mattes F, Emery V, Dusheiko GM. (1999) 'Viral dynamics in vivo of acute hepatitis B infection'. BRITISH MED JOURNAL PUBL GROUP GUT, 44, pp. A52-A52.
  • Emery VC, Atkins MC, Bowen EF, Clark DA, Johnson MA, Kidd IM, McLaughlin JE, Phillips AN, Strappe PM, Griffiths PD. (1999) 'Interactions between beta-herpesviruses and human immunodeficiency virus in vivo: evidence for increased human immunodeficiency viral load in the presence of human herpesvirus 6.'. J Med Virol, UNITED STATES: 57 (3), pp. 278-282.
  • Griffiths DJ, Cooke SP, Herve C, Rigby SP, Mallon E, Hajeer A, Lock M, Emery V, Taylor P, Pantelidis P, Bunker CB, du Bois R, Weiss RA, Venables PJW. (1999) 'Detection of human retrovirus 5 in patients with arthritis and systemic lupus erythematosus'. LIPPINCOTT WILLIAMS & WILKINS ARTHRITIS AND RHEUMATISM, 42 (3), pp. 448-454.
  • Downey GP, Emery VC, Walker PG. (1999) 'A longitudinal study of human papillomavirus 16 positivity in the development of lower genital intraepithelial neoplasia in immunosuppressed women'. Journal of Lower Genital Tract Disease, 3 (3), pp. 163-170.
  • Emery VC. (1999) 'Viral dynamics during active cytomegalovirus infection and pathology.'. Intervirology, SWITZERLAND: 42 (5-6), pp. 405-411.
  • Rankin PF, Prentice HG, Moore J, Clark DA, Potter M, Knight SN, Sabin CA, Mattes FM, Noibi SN, Emery VC, Griffiths PD. (1998) 'Significance of quantitative-competitive PCR for human herpes virus-6, human herpes virus-7 and cytomegalovirus following bone marrow transplantation.'. W B SAUNDERS CO BLOOD, 92 (10), pp. 518A-518A.
  • Hassan-Walker AF, Cope AV, Griffiths PD, Emery VC. (1998) 'Transcription of the human cytomegalovirus natural killer decoy gene, UL18, in vitro and in vivo.'. J Gen Virol, ENGLAND: 79 ( Pt 9), pp. 2113-2116.
  • Ullman CG, Chamberlain D, Ansari A, Emery VC, Haris PI, Sim RB, Perkins SJ. (1998) 'Human complement factor I: its expression by insect cells and its biochemical and structural characterisation.'. Mol Immunol, ENGLAND: 35 (9), pp. 503-512.
  • Atkins M, Strappe P, Kaye S, Loveday C, McLaughlin JE, Johnson MA, Tedder RS, Griffiths PD, Emery VC. (1998) 'Quantitative differences in the distribution of zidovudine resistance mutations in multiple post-mortem tissues from AIDS patients.'. J Med Virol, UNITED STATES: 55 (2), pp. 138-146.
  • Bowen EF, Emery VC, Wilson P, Johnson MA, Davey CC, Sabin CA, Farmer D, Griffiths PD. (1998) 'Cytomegalovirus polymerase chain reaction viraemia in patients receiving ganciclovir maintenance therapy for retinitis.'. AIDS, UNITED STATES: 12 (6), pp. 605-611.
  • Gor D, Sabin C, Prentice HG, Vyas N, Man S, Griffiths PD, Emery VC. (1998) 'Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: relationship between peak virus load, donor/recipient serostatus, acute GVHD and CMV disease.'. Bone Marrow Transplant, ENGLAND: 21 (6), pp. 597-605.
  • Griffiths PD, Feinberg JE, Fry J, Sabin C, Dix L, Gor D, Ansari A, Emery VC. (1998) 'The effect of valaciclovir on cytomegalovirus viremia and viruria detected by polymerase chain reaction in patients with advanced human immunodeficiency virus disease. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study Group.'. J Infect Dis, UNITED STATES: 177 (1), pp. 57-64.
  • Kidd IM, Clark DA, Bremner JA, Pillay D, Griffiths PD, Emery VC. (1998) 'A multiplex PCR assay for the simultaneous detection of human herpesvirus 6 and human herpesvirus 7, with typing of HHV-6 by enzyme cleavage of PCR products.'. J Virol Methods, NETHERLANDS: 70 (1), pp. 29-36.
  • Emery VC. (1998) 'Cytomegalovirus drug resistance.'. Antivir Ther, ENGLAND: 3 (4), pp. 239-242.
  • Emery VC. (1998) 'PCR in diagnostic virology: Methodological concepts'. Herpes, 5 (2), pp. 46-50.
  • Cope AV, Sabin C, Burroughs A, Rolles K, Griffiths PD, Emery VC. (1997) 'Interrelationships among quantity of human cytomegalovirus (HCMV) DNA in blood, donor-recipient serostatus, and administration of methylprednisolone as risk factors for HCMV disease following liver transplantation.'. J Infect Dis, UNITED STATES: 176 (6), pp. 1484-1490.
  • Phillips AN, McLean A, Johnson MA, Tyrer M, Emery V, Griffiths P, Bofill M, Janossy G, Loveday C. (1997) 'HIV-1 dynamics after transient antiretroviral therapy: implications for pathogenesis and clinical management.'. J Med Virol, UNITED STATES: 53 (3), pp. 261-265.
  • Bowen EF, Johnson MA, Griffiths PD, Emery VC. (1997) 'Development of a point mutation assay for the detection of human cytomegalovirus UL97 mutations associated with ganciclovir resistance.'. J Virol Methods, NETHERLANDS: 68 (2), pp. 225-234.
  • Deane M, Gor D, Macmahon ME, Emery V, Griffith PD, Cummins M, Prentice HG. (1997) 'Quantification of CMV viraemia in a case of transfusion-related graft-versus-host disease associated with purine analogue treatment.'. Br J Haematol, ENGLAND: 99 (1), pp. 162-164.
  • Fabio G, Knight SN, Kidd IM, Noibi SM, Johnson MA, Emery VC, Griffiths PD, Clark DA. (1997) 'Prospective study of human herpesvirus 6, human herpesvirus 7, and cytomegalovirus infections in human immunodeficiency virus-positive patients.'. J Clin Microbiol, UNITED STATES: 35 (10), pp. 2657-2659.
  • Clark DA, Kidd IM, Collingham KE, Tarlow M, Ayeni T, Riordan A, Griffiths PD, Emery VC, Pillay D. (1997) 'Diagnosis of primary human herpesvirus 6 and 7 infections in febrile infants by polymerase chain reaction.'. Arch Dis Child, ENGLAND: 77 (1), pp. 42-45.
  • Cope AV, Sweny P, Sabin C, Rees L, Griffiths PD, Emery VC. (1997) 'Quantity of cytomegalovirus viruria is a major risk factor for cytomegalovirus disease after renal transplantation.'. J Med Virol, UNITED STATES: 52 (2), pp. 200-205.
  • Bowen EF, Sabin CA, Wilson P, Griffiths PD, Davey CC, Johnson MA, Emery VC. (1997) 'Cytomegalovirus (CMV) viraemia detected by polymerase chain reaction identifies a group of HIV-positive patients at high risk of CMV disease.'. AIDS, UNITED STATES: 11 (7), pp. 889-893.
  • Devereux HL, Brown D, Dusheiko GM, Emery VC, Lee CA. (1997) 'Long-term evolution of the 5'UTR and a region of NS4 containing a CTL epitope of hepatitis C virus in two haemophilic patients.'. J Gen Virol, ENGLAND: 78 ( Pt 3), pp. 583-590.
  • Lao WC, Lee D, Burroughs AK, Lanzani G, Rolles K, Emery VC, Griffiths PD. (1997) 'Use of polymerase chain reaction to provide prognostic information on human cytomegalovirus disease after liver transplantation.'. J Med Virol, UNITED STATES: 51 (3), pp. 152-158.
  • O'Neil C, Lee D, Clewley G, Johnson MA, Emery VC. (1997) 'Prevalence of anti-vif antibodies in HIV-1 infected individuals assessed using recombinant baculovirus expressed vif protein.'. J Med Virol, UNITED STATES: 51 (3), pp. 139-144.
  • Lock MJ, Griffiths PD, Emery VC. (1997) 'Development of a quantitative competitive polymerase chain reaction for human herpesvirus 8.'. J Virol Methods, NETHERLANDS: 64 (1), pp. 19-26.
  • Tarar MR, Emery VC, Harrison TJ. (1996) 'Expression of a human cytomegalovirus gp58 antigenic domain fused to the hepatitis B virus nucleocapsid protein.'. FEMS Immunol Med Microbiol, NETHERLANDS: 16 (3-4), pp. 183-192.
  • Gor D, Lee D, Emery VC. (1996) 'Detection of human cytomegalovirus polymerase chain reaction products using oligonucleotide probes directly conjugated to alkaline phosphatase (vol 61, pg 145, 1996)'. ELSEVIER SCIENCE BV JOURNAL OF VIROLOGICAL METHODS, 62 (2), pp. 185-185.
  • Bowen EF, Griffiths PD, Davey CC, Emery VC, Johnson MA. (1996) 'Lessons from the natural history of cytomegalovirus.'. AIDS, UNITED STATES: 10 Suppl 1, pp. S37-S41.
  • Bowen EF, Wilson P, Cope A, Sabin C, Griffiths P, Davey C, Johnson M, Emery V. (1996) 'Cytomegalovirus retinitis in AIDS patients: influence of cytomegaloviral load on response to ganciclovir, time to recurrence and survival.'. AIDS, UNITED STATES: 10 (13), pp. 1515-1520.
  • Ullman CG, Haris PI, Galloway DA, Emery VC, Perkins SJ. (1996) 'Predicted alpha-helix/beta-sheet secondary structures for the zinc-binding motifs of human papillomavirus E7 and E6 proteins by consensus prediction averaging and spectroscopic studies of E7.'. Biochem J, ENGLAND: 319 ( Pt 1), pp. 229-239.
  • Clark DA, Ait-Khaled M, Wheeler AC, Kidd IM, McLaughlin JE, Johnson MA, Griffiths PD, Emery VC. (1996) 'Quantification of human herpesvirus 6 in immunocompetent persons and post-mortem tissues from AIDS patients by PCR.'. J Gen Virol, ENGLAND: 77 ( Pt 9), pp. 2271-2275.
  • Gor D, Lee D, Emery VC. (1996) 'Detection of human cytomegalovirus polymerase chain reaction products using oligonucleotide probes directly conjugated to alkaline phosphatase.'. J Virol Methods, NETHERLANDS: 61 (1-2), pp. 145-150.
  • Atkins MC, Carlin EM, Emery VC, Griffiths PD, Boag F. (1996) 'Fluctuations of HIV load in semen of HIV positive patients with newly acquired sexually transmitted diseases.'. BMJ, ENGLAND: 313 (7053), pp. 341-342.
  • Kidd IM, Clark DA, Ait-Khaled M, Griffiths PD, Emery VC. (1996) 'Measurement of human herpesvirus 7 load in peripheral blood and saliva of healthy subjects by quantitative polymerase chain reaction.'. J Infect Dis, UNITED STATES: 174 (2), pp. 396-401.
  • Emery VC. (1996) 'Production of Plaques in Monolayer Tissue Cultures by Single Particles of an Animal VirusReproduced from Proc. Natl Acad. Sci 38, 747-752 (1952) with kind permission of Proceedings of the National Academy of Sciences, USA.'. Rev Med Virol, 6 (2), pp. 61-64.
  • Grundy JE, Ehrnst A, Einsele H, Emery VC, Hebart H, Prentice HG, Ljungman P. (1996) 'A three-center European external quality control study of PCR for detection of cytomegalovirus DNA in blood.'. J Clin Microbiol, UNITED STATES: 34 (5), pp. 1166-1170.
  • Ullman CG, Emery VC. (1996) 'Transforming Proteins of Human Papillomaviruses.'. Rev Med Virol, 6 (1), pp. 39-55.
  • Ullman CG, Harris PI, Smith KF, Sim RB, Emery VC, Perkins SJ. (1996) 'beta-Sheet secondary structure of an LDL receptor domain from complement factor I by consensus structure predictions and spectroscopy (vol 371, pg 199, 1995)'. ELSEVIER SCIENCE BV FEBS LETTERS, 379 (2), pp. 201-201.
  • Emery VC. (1996) 'Zidovudine resistance and HIV-1 load in multiple autopsy tissues of AIDS patients'. Pediatric AIDS and HIV Infection, 7 (5)
  • Devereux H, Telfer P, Brown D, Morris A, Dusheiko G, Emery V, Lee C. (1996) 'Longitudinal genotype analysis and quantification of hepatitis C virus in haemophilic patients receiving interferon-alpha therapy.'. J Viral Hepat, ENGLAND: 3 (1), pp. 43-48.
  • Webster A, Emery VC. (1996) 'Developments in anti-herpesvirus therapy'. Reviews in Contemporary Pharmacotherapy, 7 (2), pp. 75-89.
  • Bowen EF, Wilson P, Atkins M, Madge S, Griffiths PD, Johnson MA, Emery VC. (1995) 'Natural history of untreated cytomegalovirus retinitis.'. Lancet, ENGLAND: 346 (8991-8992), pp. 1671-1673.
  • Bowen EF, Wilson P, Atkins M, Madge S, Griffiths PD, Johnson MA, Emery VC. (1995) 'Natural history of untreated cytomegalovirus retinitis'. LANCET LTD LANCET, 346 (8991-2), pp. 1671-1673.
  • Ullman CG, Haris PI, Smith KF, Sim RB, Emery VC, Perkins SJ. (1995) 'β-Sheet secondary structure of an LDL receptor domain from complement factor I by consensus structure predictions and spectroscopy'. FEBS Letters, 371 (2), pp. 199-203.
  • ULLMAN CG, HARIS PI, SMITH KF, SIM RB, EMERY VC, PERKINS SJ. (1995) 'BETA-SHEET SECONDARY STRUCTURE OF AN LDL RECEPTOR DOMAIN FROM COMPLEMENT FACTOR-I BY CONSENSUS STRUCTURE PREDICTIONS AND SPECTROSCOPY'. ELSEVIER SCIENCE BV FEBS LETTERS, 371 (2), pp. 199-203.
  • Webster A, McLaughlin JE, Johnson MA, Emery VC, Griffiths PD. (1995) 'Use of the polymerase chain reaction to detect genomes of human immunodeficiency virus and cytomegalovirus in post-mortem tissues.'. J Med Virol, UNITED STATES: 47 (1), pp. 23-28.
  • Ait-Khaled M, McLaughlin JE, Johnson MA, Emery VC. (1995) 'Distinct HIV-1 long terminal repeat quasispecies present in nervous tissues compared to that in lung, blood and lymphoid tissues of an AIDS patient.'. AIDS, UNITED STATES: 9 (7), pp. 675-683.
  • MOCROFT AJ, JOHNSON MA, SABIN CA, LIPMAN M, ELFORD J, EMERY V, MORCINEK J, YOULE M, JANOSSY G, LEE CA, PHILLIPS AN. (1995) 'STAGING SYSTEM FOR CLINICAL AIDS PATIENTS'. LANCET LTD LANCET, 346 (8966), pp. 12-17.
  • Mocroft AJ, Johnson MA, Sabin CA, Lipman M, Elford J, Emery V, Morcinek J, Youle M, Janossy G, Lee CA. (1995) 'Staging system for clinical AIDS patients. Royal Free/Chelsea and Westminster Hospitals Collaborative Group.'. Lancet, ENGLAND: 346 (8966), pp. 12-17.
  • Sabin CA, Phillips AN, Lee CA, Janossy G, Emery V, Griffiths PD. (1995) 'The effect of CMV infection on progression of human immunodeficiency virus disease is a cohort of haemophilic men followed for up to 13 years from seroconversion.'. Epidemiol Infect, ENGLAND: 114 (2), pp. 361-372.
  • Fox JC, Kidd IM, Griffiths PD, Sweny P, Emery VC. (1995) 'Longitudinal analysis of cytomegalovirus load in renal transplant recipients using a quantitative polymerase chain reaction: correlation with disease.'. J Gen Virol, ENGLAND: 76 ( Pt 2), pp. 309-319.
  • Emery VC. (1995) 'Nucleoside analogues as antiviral agents: Learning from experience?'. International Antiviral News, 3 (3), pp. 42-44.
  • Strappe P, Atkins M, Kaye S, Loveday C, Johnson M, Tedder R, Griffiths PD, Emery VC. (1995) 'Distribution quantity of zidovudine-resistant genotypes in multiple organs of HIV-infected patients dying with AIDS'. LIPPINCOTT WILLIAMS & WILKINS JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 10, pp. 79-79.
  • Downey GP, Bavin PJ, Deery A, Crow J, Griffiths PD, Emery VC, Walker PG. (1995) 'Relation between human papillomavirus type 16 and potential for progression of minor-grade cervical disease'. ACOG Current Journal Review, 8 (1)
  • Phillips AN, Mocroft A, Emery V, Janossy G, Johnson M. (1995) 'Mathematical model of the effects of therapy and resistance to therapy in primary HIV infection'. LIPPINCOTT-RAVEN PUBL JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 10, pp. 83-83.
  • Ullman CG, Haris PI, Kell B, Cason J, Jewers RJ, Best JM, Emery VC, Perkins SJ. (1994) 'Hypothetical structure of the membrane-associated E5 oncoprotein of human papillomavirus type 16.'. Biochem Soc Trans, ENGLAND: 22 (4)
  • Downey GP, Bavin PJ, Deery AR, Crow J, Griffiths PD, Emery VC, Walker PG. (1994) 'Relation between human papillomavirus type 16 and potential for progression of minor-grade cervical disease.'. Lancet, ENGLAND: 344 (8920), pp. 432-435.
  • Ait-Khaled M, Emery VC. (1994) 'Phylogenetic relationship between human immunodeficiency virus type 1 (HIV-1) long terminal repeat natural variants present in the lymph node and peripheral blood of three HIV-1-infected individuals.'. J Gen Virol, ENGLAND: 75 ( Pt 7), pp. 1615-1621.
  • Gillespie SH, Ullman C, Smith MD, Emery V. (1994) 'Detection of Streptococcus pneumoniae in sputum samples by PCR.'. J Clin Microbiol, UNITED STATES: 32 (5), pp. 1308-1311.
  • GRIFFITHS PD, EMERY VC, LEE C, JOHNSON MA, MCLAUGHLIN J. (1994) 'HHV-6 IN AIDS'. LANCET LTD LANCET, 343 (8905), pp. 1104-1105.
  • Downey GP, Bavin PJ, Deery ARS, Griffiths PD, Emery VC, Walker PG. (1994) 'The relationship between HPV 16 semi-quantitation and the potential for progression of minor grade cervical disease'. British Journal of Obstetrics and Gynaecology, 101 (3)
  • PHILLIPS AN, SABIN CA, ELFORD J, BOFILL M, EMERY V, GRIFFITHS PD, JANOSSY G, LEE CA. (1994) 'VIRAL BURDEN IN HIV-INFECTION'. MACMILLAN MAGAZINES LTD NATURE, 367 (6459), pp. 124-124.
  • Ait-Khaled M, Emery VC. (1993) 'Sequence variation within the human immunodeficiency virus V3 loop at seroconversion.'. J Med Virol, UNITED STATES: 41 (4), pp. 270-274.
  • Roy DM, Grundy JE, Emery VC. (1993) 'Sequence variation within neutralizing epitopes of the envelope glycoprotein B of human cytomegalovirus: comparison of isolates from renal transplant recipients and AIDS patients.'. J Gen Virol, ENGLAND: 74 ( Pt 11), pp. 2499-2505.
  • Kidd IM, Fox JC, Pillay D, Charman H, Griffiths PD, Emery VC. (1993) 'Provision of prognostic information in immunocompromised patients by routine application of the polymerase chain reaction for cytomegalovirus.'. Transplantation, UNITED STATES: 56 (4), pp. 867-871.
  • Kidd IM, Emery VC. (1993) 'The use of baculoviruses as expression vectors.'. Appl Biochem Biotechnol, UNITED STATES: 42 (2-3), pp. 137-159.
  • Bavin PJ, Walker PG, Emery VC. (1993) 'Sequence microheterogeneity in the long control region of clinical isolates of human papillomavirus type 16.'. J Med Virol, UNITED STATES: 39 (4), pp. 267-272.
  • Bavin PJ, Giles JA, Deery A, Crow J, Griffiths PD, Emery VC, Walker PG. (1993) 'Use of semi-quantitative PCR for human papillomavirus DNA type 16 to identify women with high grade cervical disease in a population presenting with a mildly dyskaryotic smear report.'. Br J Cancer, ENGLAND: 67 (3), pp. 602-605.
  • Emery VC, Webster A, Griffiths PD. (1993) 'Molecular and cell biology of opportunistic infections in AIDS. Herpesviruses.'. Mol Cell Biol Hum Dis Ser, ENGLAND: 2, pp. 257-277.
  • FOX JC, EMERY VC. (1992) 'QUANTIFICATION OF VIRUSES IN CLINICAL-SAMPLES'. JOHN WILEY & SONS LTD REVIEWS IN MEDICAL VIROLOGY, 2 (4), pp. 195-203.
  • WAKEFIELD AJ, FOX JD, SAWYERR AM, TAYLOR JE, SWEENIE CH, SMITH M, EMERY VC, HUDSON M, TEDDER RS, POUNDER RE. (1992) 'DETECTION OF HERPESVIRUS DNA IN THE LARGE-INTESTINE OF PATIENTS WITH ULCERATIVE-COLITIS AND CROHNS-DISEASE USING THE NESTED POLYMERASE CHAIN-REACTION'. WILEY-LISS JOURNAL OF MEDICAL VIROLOGY, 38 (3), pp. 183-190.
  • TUDORWILLIAMS G, EMERY VC. (1992) 'DEVELOPMENT OF INVITRO RESISTANCE TO ZIDOVUDINE IS LIKELY TO BE CLINICALLY SIGNIFICANT'. JOHN WILEY & SONS LTD REVIEWS IN MEDICAL VIROLOGY, 2 (3), pp. 123-129.
  • Fox JC, Griffiths PD, Emery VC. (1992) 'Quantification of human cytomegalovirus DNA using the polymerase chain reaction.'. J Gen Virol, ENGLAND: 73 ( Pt 9), pp. 2405-2408.
  • Yi CK, Charalambous BM, Emery VC, Baldwin SA. (1992) 'Characterization of functional human erythrocyte-type glucose transporter (GLUT1) expressed in insect cells using a recombinant baculovirus.'. Biochem J, ENGLAND: 283 ( Pt 3), pp. 643-646.
  • Bavin PJ, Giles JA, Hudson E, Williams D, Crow J, Griffiths PD, Emery VC, Walker PG. (1992) 'Comparison of cervical cytology and the polymerase chain reaction for HPV 16 to identify women with cervical disease in a general practice population.'. J Med Virol, UNITED STATES: 37 (1), pp. 8-12.
  • Emery VC. (1992) 'Baculovirus expression vectors.'. Methods Mol Biol, United States: 8, pp. 319-326.
  • Emery VC. (1992) 'Baculovirus expression vectors.'. Methods Mol Biol, United States: 8, pp. 309-318.
  • Emery VC. (1992) 'Baculovirus expression vectors : choice of expression vector.'. Methods Mol Biol, United States: 8, pp. 287-307.
  • Fox JC, Ait-Khaled M, Webster A, Emery VC. (1991) 'Eliminating PCR contamination: is UV irradiation the answer?'. J Virol Methods, NETHERLANDS: 33 (3), pp. 375-382.
  • Darlington J, Super M, Patel K, Grundy JE, Griffiths PD, Emery VC. (1991) 'Use of the polymerase chain reaction to analyse sequence variation within a major neutralizing epitope of glycoprotein B (gp58) in clinical isolates of human cytomegalovirus.'. J Gen Virol, ENGLAND: 72 ( Pt 8), pp. 1985-1989.
  • MCLEAN AR, EMERY VC, WEBSTER A, GRIFFITHS PD. (1991) 'POPULATION-DYNAMICS OF HIV WITHIN AN INDIVIDUAL AFTER TREATMENT WITH ZIDOVUDINE'. RAPID SCIENCE PUBLISHERS AIDS, 5 (5), pp. 485-489.
  • Emery VC. (1991) 'Baculovirus expression vectors for the production of viral proteins'. Reviews in Medical Virology, 1 (1), pp. 11-17.
  • Emery VC, Griffiths PD. (1990) 'Molecular biology of cytomegalovirus.'. Int J Exp Pathol, ENGLAND: 71 (6), pp. 905-918.
  • ORCHARD K, PERKINS N, CHAPMAN C, HARRIS J, EMERY V, GOODWIN G, LATCHMAN D, COLLINS M. (1990) 'A T-CELL PROTEIN WHICH RECOGNIZES A PALINDROMIC DNA-SEQUENCE IN THE NEGATIVE REGULATORY ELEMENT OF THE HIV-1 LONG TERMINAL REPEAT WITH HOMOLOGY TO STEROID THYROID-HORMONE RECEPTOR-BINDING SITES'. PORTLAND PRESS BIOCHEMICAL SOCIETY TRANSACTIONS, 18 (4), pp. 555-556.
  • ORCHARD K, PERKINS N, CHAPMAN C, HARRIS J, EMERY V, GOODWIN G, LATCHMAN D, COLLINS M. (1990) 'A NOVEL T-CELL PROTEIN WHICH RECOGNIZES A PALINDROMIC SEQUENCE IN THE NEGATIVE REGULATORY ELEMENT OF THE HUMAN-IMMUNODEFICIENCY-VIRUS LONG TERMINAL REPEAT'. AMER SOC MICROBIOLOGY JOURNAL OF VIROLOGY, 64 (7), pp. 3234-3239.
  • Emery VC, Griffiths PD. (1990) 'Molecular biology of cytomegalovirus.'. International journal of experimental pathology, 71 (6), pp. 905-918.
  • WEBSTER A, LEE CA, COOK DG, GRUNDY JE, EMERY VC, KERNOFF PBA, GRIFFITHS PD. (1989) 'CYTOMEGALO-VIRUS INFECTION AND PROGRESSION TO AIDS'. LANCET LTD LANCET, 2 (8664), pp. 681-681.
  • Webster A, Lee CA, Cook DG, Grundy JE, Emery VC, Kernoff PB, Griffiths PD. (1989) 'Cytomegalovirus infection and progression towards AIDS in haemophiliacs with human immunodeficiency virus infection.'. Lancet, ENGLAND: 2 (8654), pp. 63-66.

Conference papers

  • Egli A, Lisboa L, O'Shea D, Emery V, Asberg A, Hartmann A, Kumar D, Humar A. (2013) 'A Complex Host MicroRNA Response to Cytomegalovirus Infection: A Bench to Bedside Analysis'. WILEY-BLACKWELL AMERICAN JOURNAL OF TRANSPLANTATION, Seattle, WA: 13th American Transplant Congress (ATC) 13, pp. 57-57.
  • Emery VC, Rose J, Manuel O, Humar A, Asberg A, Neumann A. (2012) 'A Full Dynamic Model To Explain Declines in Cytomegalovirus (CMV) Load after Ganciclovir Therapy in Patients with CMV Disease'. WILEY-BLACKWELL AMERICAN JOURNAL OF TRANSPLANTATION, Boston, MA: American Transplant Congress 12, pp. 69-69.
  • Atabani SF, Atkinson CE, Aldridge RW, Harber M, Emery VC, Griffiths PD. (2011) 'Pre-Emptive Therapy for the Prevention of CMV Infection Post Solid Organ Transplantation: The London Experience'. WILEY-BLACKWELL AMERICAN JOURNAL OF TRANSPLANTATION, Philadelphia, PA: American Transplant Congress 11, pp. 456-456.
  • Gamett G, Boeckh M, Einsele H, Emery V. (2009) 'The natural history and control of cytomegalovirus infection following allogeneic stem cell transplantation'. NATURE PUBLISHING GROUP BONE MARROW TRANSPLANTATION, Goteborg, SWEDEN: 35th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation 43, pp. S237-S238.
  • Manuel O, Pang X, Preiksaitis JK, Emery VC, Kumar D, Asberg A, Hartmann A, Pescovitz MD, Bignamini AA, Rollag H, Jardine AG, Humar A. (2008) 'A prospective study of viral genetic polymorphisms in CMV glycoprotein B and their association with clinical and virologic outcomes in patients with CMV disease'. WILEY-BLACKWELL AMERICAN JOURNAL OF TRANSPLANTATION, Toronto, CANADA: 8th American Transplant Congress 8, pp. 184-184.
  • Nebbia G, Grillo F, Clewley G, Burroughs AK, Emery VC. (2008) 'Comparison of hepatitis C replication dynamics during acute infection in immunocompetent hosts and re-infection of the donor liver after transplantation'. WILEY-BLACKWELL PUBLISHING, INC AMERICAN JOURNAL OF TRANSPLANTATION, Toronto, CANADA: 8th American Transplant Congress 8, pp. 634-634.
  • Nebbia G, Northfield J, Barnes E, Emery V, Brown D, Willberg C, Dusheiko G, Klenerman P, Fabris P. (2006) 'Role of circulating IL-10 in acute viral hepatitis'. ELSEVIER SCIENCE BV JOURNAL OF HEPATOLOGY, Vienna, AUSTRIA: 41st Annual Meeting of the European-Association-for-the-Study-of-the-Liver 44, pp. S149-S150.
  • Buyck HC, Paston SJ, Lowdell MW, MacKinnon S, Emery VC. (2004) 'Functional helper T cell response to CMV predicts probability of CMV vireamia following allogeneic stem cell transplantation.'. AMER SOC HEMATOLOGY BLOOD, San Diego, CA: 46th Annual Meeting of the American-Society-of-Hematology 104 (11), pp. 611A-611A.
  • Mattes FM, Hainsworth EG, Hassan-Walker AF, Burroughs AK, Sweny P, Griffiths PD, Emery VC. (2004) 'Kinetics of CMV load reductions following pre-emptive therapy with valganciclovir or intravenous ganciclovir in adult solid organ transplant patients'. WILEY-BLACKWELL AMERICAN JOURNAL OF TRANSPLANTATION, Boston, MA: 5th American Transplant Congress 4, pp. 535-535.
  • Fryer J, Emery V, Griffiths P, Clark D. (2003) 'Susceptibility of porcine cytomegalovirus to antiviral drugs'. BLACKWELL MUNKSGAARD XENOTRANSPLANTATION, GLASGOW, SCOTLAND: 7th Congress of the International-Xenotransplantation-Association 10 (5), pp. 520-520.
  • Hassan-Walker AF, Emery VC, Griffiths PD. (2002) 'Molecular diagnosis of cytomegalovirus disease'. CAMBRIDGE UNIV PRESS BIOMARKERS OF DISEASE: AN EVIDENCE-BASED APPROACH, CAMBRIDGE, ENGLAND: EMBODY 2000 Conference, pp. 467-473.
  • Soderberg-Naucler C, Emery VC. (2001) 'Viral infections and their impact on chronic renal allograft dysfunction'. LIPPINCOTT WILLIAMS & WILKINS TRANSPLANTATION, ROME, ITALY: Symposium on Redefining Expectations in Transplantation - Chronic Renal Allograft Dysfunction 71 (11), pp. SS24-SS30.
  • Zanghellini F, Boppana SB, Emery VC, Griffiths PD, Pass RF. (1999) 'Asymptomatic primary cytomegalovirus infection: Virologic and immunologic features'. OXFORD UNIV PRESS INC JOURNAL OF INFECTIOUS DISEASES, ORANGE BEACH, AL: 6th International Cytomegalovirus Workshop 180 (3), pp. 702-707.
  • Griffiths PD, Feinberg JE, Fry J, Sabin C, Dix L, Gor D, Ansari A, Emery VC. (1998) 'The effect of valaciclovir on cytomegalovirus viremia and viruria detected by polymerase chain reaction in patients with advanced human immunodeficiency virus disease'. UNIV CHICAGO PRESS JOURNAL OF INFECTIOUS DISEASES, WASHINGTON, D.C.: 3rd National Conference on Retroviruses and Opportunistic Infections 177 (1), pp. 57-64.
  • Emery VC. (1998) 'Relative importance of cytomegalovirus load as a risk factor for cytomegalovirus disease in the immunocompromised host'. KARGER CMV-RELATED IMMUNOPATHOLOGY, FRANKFURT, GERMANY: 1st International Consensus Round Table Meeting on CMV-Related Immunopathology 21, pp. 288-301.
  • JEFFRIES D, BARTON S, JOHNSON R, EMERY V. (1994) 'ISSUES IN HERPES MANAGEMENT'. BLACKWELL SCIENCE LTD ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, ZERMATT, SWITZERLAND: Working on Evaluating New Antiviral Drugs 5, pp. 23-29.

Page Owner: ve0004
Page Created: Wednesday 17 October 2012 10:45:57 by pr0004
Last Modified: Monday 23 May 2016 14:55:31 by cd0027
Expiry Date: Friday 17 January 2014 10:44:42
Assembly date: Tue Jun 28 18:00:58 BST 2016
Content ID: 92336
Revision: 9
Community: 1196

Rhythmyx folder: //Sites/surrey.ac.uk/Microbial Sciences/People
Content type: rx:StaffProfile